REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/30/2026
Back to search
Official data from USPTO
GBS MED-PHARM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
03/31/2026
Trademark type
Combined
Nice classes
35
Filing date
04/29/2020
Registration date
03/30/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/30/2021
Last transaction
03/31/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
11/18/2012
First use in commerce
11/18/2012
Drawing code
3
Owner type
01
Owner location
Bowie, MD, US
Examiner
VERHOSEK, WILLIAM T
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a blue circle design with two intersecting green rings around the circle. Inside the blue circle design are two white leaves above the letters "GBS" in white which is all above the wording "MED-PHARM" where "MED-" is in blue and "PHARM" is in green.
Holders and representatives
Holders
G. S. (pessoa física)
Representatives
GREGORY BARRINGTON SUMNER GREGORY BARRINGTON SUMNER
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Online retail stores featuring medical supplies and equipmenthealth and beauty products
Publications
History of USPTO decisions and trademark events.
35 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/30/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/12/2021
PUBO
PUBLISHED FOR OPPOSITION
01/12/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/23/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/10/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/02/2020
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
12/01/2020
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
11/17/2020
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
10/20/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/08/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
10/05/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/05/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
10/05/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/05/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/26/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/26/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/24/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/21/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/21/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/10/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/10/2020
GNFR
FINAL REFUSAL E-MAILED
09/10/2020
CNFR
FINAL REFUSAL WRITTEN
09/10/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/03/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/03/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/28/2020
CEPE
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
07/28/2020
ALIE
ASSIGNED TO LIE
07/28/2020
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
07/28/2020
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
07/28/2020
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
07/28/2020
DOCK
ASSIGNED TO EXAMINER
07/23/2020
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/13/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/12/2020
Continuous trademark protection
Get notified about every new filing that threatens GBS MED-PHARM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.